🇰🇷 South Korea Country × Condition
heart failure Clinical Trials in South Korea
Active clinical trials for heart failure with research sites in South Korea. All data sourced live from ClinicalTrials.gov — updated daily.
Active Trials: 3 // Recruiting: 3 Phases: Phase 4 // Updated: Daily
Total Trials
3
Recruiting Now
3
Country
🇰🇷 South Korea
Active Trials in South Korea (3)
NCT05672836 Phase 4
Recruiting
ENAVOgliflozin Outcome Trial in Patients With Severe Aortic Stenosis After Transcatheter Aortic Valve Replacement
Enrollment
1,040 pts
Country
🇰🇷 South Korea
Duk-Woo Park, MD
View Trial → NCT06978998
Recruiting
Validation of the Prognostic Impact of a Retinal Photograph-based Cardiovascular Disease Risk Stratification System in de Novo HFrEF
Enrollment
100 pts
Country
🇰🇷 South Korea
Yonsei University
View Trial → NCT07631156 Phase 4
Recruiting
STEPwise De-escalation and Optimizing Withdrawal of ARNI and SGLT2i in Normalized Heart Failure
Enrollment
80 pts
Country
🇰🇷 South Korea
Kyungsub Song
View Trial → Frequently Asked Questions
How many heart failure clinical trials are active in South Korea?
There are currently 3 active clinical trials for heart failure with sites in South Korea, of which 3 are actively recruiting patients.
How can I join a heart failure clinical trial in South Korea?
To join a heart failure clinical trial in South Korea, select a recruiting trial below and check the eligibility criteria. Contact the trial's principal investigator or the listed site in South Korea directly. All trials listed here are sourced from ClinicalTrials.gov, the official U.S. registry of clinical studies.
What phases are heart failure trials in South Korea?
Active heart failure trials in South Korea span Phase 4. Phase I trials test safety, Phase II test efficacy, and Phase III compare against standard treatments in larger patient populations.
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: November 2026 · Data Methodology